Opinion

Armando Orlandi: To explain the unexplainable in MONARCH 3

Photo taken from Armando Orlandi/X

Jun 10, 2024, 10:31

Armando Orlandi: To explain the unexplainable in MONARCH 3

Armando Orlandi, Medical Oncologist at Agostino Gemelli University Policlinic, made the following post on X:

“To explain the unexplainable in MONARCH 3 overall survival: the Restricted Mean Survival Time (RMST). Letter to the Editor regarding Final overall survival results of MONARCH 3’ by M. P. Goetz et al. – Annals of Oncology.”

Read further.
Source: Armando Orlandi/X

Agostino Gemelli University Policlinic Annals of Oncology Armando Orlandi cancer clinical trial results Letter to the Editor M. P. Goetz medical oncologist MONARCH 3 OncoDaily Oncology oncology research overall survival Restricted Mean Survival Time (RMST)

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Special Coverage